Stock A204840 GL PHARM TECH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights GL Pharm Tech Corp.

Equities

A204840

KR7204840003

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/06/2024 BST 		5-day change 1st Jan Change
1,203 KRW +0.92% Intraday chart for GL Pharm Tech Corp. +3.35% +5.90%
05-03 An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion. CI
03-06 W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion.
CI
W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund
CI
W Science Co., Ltd. agreed to acquire a 14.7% stake in GL Pharm Tech Corp.
CI
GL Pharm Tech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GL Pharm Tech Corp. completed the acquisition of remaining 67.91% stake in Crown Pharm Co., Ltd.
CI
GL Pharm Tech Corp. agreed to acquire remaining 67.91% stake in Crown Pharm Co., Ltd. for KRW 3 billion.
CI
GL Pharm Tech Corp. agreed to acquire a 32.1% stake in Crown Pharmaceutical Co., Ltd. from Seungho Shin for KRW 1.4 billion.
CI
GL Pharm Tech Corp. announced that it expects to receive KRW 7 billion in funding from SBI Investment Korea Co., Ltd., MAGNA Investment Co., Ltd., KB Investment Co., Ltd.
CI
An undisclosed buyer acquired 5.3% stake in GL Pharm Tech Corp. from With Investment Co., Ltd.
CI
An undisclosed buyer acquired a 5.3% stake in GL Pharm Tech Corp. from Susung Asset Management Co., Ltd.
CI
GL PharmTech Corp. completed the acquisition of IBKS No.2 Special Purpose Acquisition Company in a reverse merger transaction.
CI
Gl Pharm Tech Corporation agreed to acquire IBKS No.2 Special Purpose Acquisition Company in a reverse merger transaction.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A204840 Stock
  4. News GL Pharm Tech Corp.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW